SCI-110 in the Treatment of Tourette Syndrome (NCT05126888)
A Randomized, Double-Blind, Placebo Controlled, Cross-Over Study to Evaluate the Efficacy, Safety and Tolerability of Daily Oral SCI-110 in Treating Adults With Tourette Syndrome.
🩺 Plain-English Summary (8th-Grade Level)
To evaluate the efficacy, safety and tolerability of the cannabinoid-based medication SCI-110 compared to placebo in subjects with Tourette syndrome.
Who can join: Review the eligibility criteria below.
Location: Yale Child Study Center - NIHB 205 — New Haven, Connecticut
Age range: 18 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- Yale Child Study Center - NIHB 205 — New Haven, Connecticut
- Medizinische Hochschule Hannover — Hanover,
- Neurological Institute, Tel Aviv Sourasky Medical Center — Tel Aviv,
📞 Contact the Study Coordinator
Phone: 972-3-7175777
Email: adi@scisparc.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Tourette Syndrome
- Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome — Sun City, Arizona
- A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Dothan, Alabama
- Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression — Gainesville, Florida
- Trajectories of Change in Tourette Syndrome — Minneapolis, Minnesota
- Sensory Symptoms in Tourette Syndrome — Nashville, Tennessee
Explore by condition: All Tourette Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.